Mabpharm Limited (HKG:2181)

Hong Kong · Delayed Price · Currency is HKD

0.4100

+0.0050 (1.23%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	258.23M	87.16M	55.92M	82.88M		14.07M
Pharmaceuticals Growth	196.27%	55.87%	-32.53%	-		-41.18%
Total	258.23M	87.16M	55.92M	82.88M		14.07M
Total Growth	196.27%	55.87%	-32.53%	-		-41.18%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
PRC	258.23M	87.16M	55.92M	82.88M		14.07M
PRC Growth	196.27%	55.87%	-32.53%	-		-41.18%
Total	258.23M	87.16M	55.92M	82.88M		14.07M
Total Growth	196.27%	55.87%	-32.53%	-		-41.18%

Source: S&P Global Market Intelligence.